Apigenin inhibits TGF-β1 induced fibroblast-to-myofibroblast transition in human lung fibroblast populations.

Journal Title: Pharmacological Reports - Year 2013, Vol 65, Issue 1

Abstract

Background: Flavonoids are dietary plant compounds suspected to reduce the incidence of chronic diseases in several regions of the world. Due to anti-allergic and anti-inflammatory activities, apigenin (4',5,7,-trihydroxyflavone) is thought to interfere with crucial events in the pathomechanism of asthma. However, the effect of apigenin on TGF-β-induced fibroblast-to-myofibroblast transition (FMT) in human lung fibroblast populations, a key event in asthma progression, has not yet been addressed. Methods: Primary human bronchial fibroblasts (HBFs) propagated from ex vivo bronchial biopsies derived from patients with diagnosed asthma and human embryonic lung IMR-90 fibroblasts were cultured in vitro and treated with TGF-β1 and apigenin. The myofibroblast fraction in fibroblast populations was evaluated by immunocytochemistry. Expression of α-smooth muscle actin (α-SMA) and tenascin C were assessed at the mRNA and protein level by real-time RT-PCR and immunoblotting, respectively. Additionally, proliferation and viability tests and time lapse-monitoring of movement of individual HBFs and IMR-90 cells were evaluated. Results: We show that apigenin attenuates TGF-β1-induced FMT in cultures of HBFs, and the magnitude of this attenuation was found to be similar to that observed in the established cell line of lung IMR-90 fibroblasts. Notably, FMT inhibition was observed at low (≈10 μM), non-cytotoxic and non-cytostatic apigenin concentrations and could be correlated with the inhibition of α-SMA and tenascin C expression in HBFs at the mRNA level. Conclusions: Our data are the first to demonstrate that apigenin inhibits the TGF-β1-induced expansion of hyper-contractile, α-smooth muscle actin - positive myofibroblasts within populations of HBFs derived from asthmatic patients. They also indicate the possible interference of apigenin with bronchial wall remodeling during the asthmatic process in vivo.

Authors and Affiliations

Katarzyna Wójcik, Marta Skoda, Paulina Koczurkiewicz, Marek Sanak, Jarosław Czyż

Keywords

Related Articles

Serotonin 2A receptor gene (HTR2A) polymorphism in alcohol-dependent patients.

Background: The serotonergic (5-HT) dysfunction has been frequently described in subjects with alcohol dependence (AD). In the present study, a potential relationship between T102C polymorphism in the 5-HT receptor subty...

Effects of statins on nitric oxide/cGMP signaling in human umbilical vein endothelial cells.

Human umbilical vein endothelial cells (HUVECs) were established as in vitro models for the modulation of endothelial function and cell viability by statins. Emphasis was placed on the biphasic effects of the drugs on ni...

Flowers for Algernon: steroid dysgenesis, epigenetics and brain disorders.

While a recent study has reported that early citalopram exposure alters cortical network function and produces autistic-like behaviors in male rats, when evaluating antidepressant animal models of autism spectrum disorde...

Effects of ischemia-reperfusion and pretreatment with mildronate on rat liver mitochondrial function.

Mildronate (3-(2,2,2-trimethylhydrazinium) propionate), which is mostly used in cardiological practice and is considered an anti-ischemic drug, was designed to inhibit carnitine biosynthesis in order to prevent accumulat...

RM-11, an isoxazole derivative, accelerates restoration of the immune function in mice treated with cyclophosphamide.

The aim of this study was to evaluate efficacy of an isoxazole derivative RM11 to accelerate reconstitution of selected immune activities in cyclophosphamide (CP)-immunocompromised mice. We demonstrated that administrati...

Download PDF file
  • EP ID EP130590
  • DOI -
  • Views 78
  • Downloads 0

How To Cite

Katarzyna Wójcik, Marta Skoda, Paulina Koczurkiewicz, Marek Sanak, Jarosław Czyż (2013). Apigenin inhibits TGF-β1 induced fibroblast-to-myofibroblast transition in human lung fibroblast populations.. Pharmacological Reports, 65(1), 164-172. https://europub.co.uk/articles/-A-130590